logo

FDA Calendar

Share
Company Name Agios Pharmaceuticals, Inc.
Drug Name TIBSOVO (sNDA)
Event Name FDA decision on TIBSOVO for newly diagnosed acute myeloid leukemia with IDH1 mutation
Event Date 06/21/2019
Outcome Date
Outcome
Drug Status priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar